查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1771508

全球智慧治疗设备市场：市场规模、份额、趋势分析（按设备、分布、最终用途和地区）、细分市场预测（2025-2030 年）

Smart Therapeutic Devices Market Size, Share & Trends Analysis Report By Devices, By Distribution (Pharmacies, Online Channel, Direct-to-Consumer (DTC)), By End Use (Hospitals, Clinics, Home Care), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

智慧医疗器材市场摘要

预计 2024 年全球智慧治疗设备市场规模为 771.2 亿美元，到 2030 年将达到 1,594.2 亿美元，2025 年至 2030 年的复合年增长率为 12.99%。这一增长得益于技术进步、慢性病患病率上升以及个人化医疗和居家医疗需求的不断增长。

这一增长得益于技术进步、慢性病患病率上升以及个性化居家照护需求的不断增长。此外，携带式连网设备（例如胰岛素帮浦、智慧吸入器和神经刺激系统）的普及率也不断提高，这些设备显着增强了疾病管理能力，尤其是在糖尿病、气喘、慢性阻塞性肺病和神经系统疾病方面。人工智慧、数据追踪和无线连接的整合实现了即时监测、患者参与和临床决策，从而改善了治疗效果并提高了患者依从性。

由于慢性病管理需要持续护理，智慧治疗设备可以弥合门诊和居家医疗之间的差距，最终有助于改善生活品质并降低住院率。例如，Omron Healthcare于2022年7月推出了可携带式氧气设备，该设备采用PSA技术，以每分钟5公升的速度输送纯度超过90%的氧气。该设备专为家庭护理而设计，结构紧凑耐用，并配有脚轮，方便移动。

此外，个人化医疗趋势持续加速智慧科技的普及。例如，2024年2月，Tandem Diabetes Care 推出了 Tandem Mobi，这是全球最小巧耐用的自动化胰岛素输送系统。这款紧凑型穿戴式装置可透过 iOS 系统实现完全的行动控制，采用先进的 Control-IQ 技术，并与 Dexcom CGM 相容，为 6 岁及以上用户提供个人化胰岛素治疗。

根据世界卫生组织（WHO）统计，截至2024年，包括心血管疾病、癌症、糖尿病和慢性呼吸系统疾病在内的非传染性疾病（NCD）占全球年度死亡人数的74%以上。为此，WHO正在积极推动增加对数位医疗解决方案（包括远端医疗和行动医疗技术）的投资，以此作为管理和减少NCD影响的经济有效的策略。特别是，预计未来十年，每位患者每年仅需在数位医疗干预方面投资0.24美元，就能挽救200多万人的生命，并预防近700万例急性疾病和住院治疗，从而显着缓解全球医疗体系的压力。

当今世界的需求正推动医疗技术供应商扩展其智慧治疗设备组合併使其更加多样化。一个典型的例子是ReSound Vivia，它号称是全球最小的人工智慧助听器，由GN于2025年2月推出。这款助听器经过1350万个真实句子的训练，显着提高了嘈杂环境中的语音清晰度，同时提供长达30小时的持久电池续航时间，可满足全天使用。 GN ReSound也推出了ReSound Savi，这是一个以价值主导的产品系列，具有蓝牙LE音讯和Auracast广播功能。

新冠疫情显着增加了对可携带式氧气设备和人工呼吸器等智慧型治疗设备的需求，这些设备已成为管理呼吸系统併发症的关键。由于人们对呼吸系统疾病的认识不断提高，智慧吸入器、连网吸入器和慢性阻塞性肺病 (COPD) 管理工具备受关注。同时，胰岛素帮浦、穿戴式註射器和植入式给药系统也有助于减少慢性疾病患者的就诊次数。疫情也透过远端医疗整合促进了神经刺激和助听设备的普及。

目录

第一章 分析方法与范围

第二章执行摘要

第三章 市场驱动因素、趋势与范围

  • 市场联动展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
    • 产业机会分析
    • 产业问题分析
    • 案例研究
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTEL分析
  • COVID-19影响分析

第四章智慧医疗设备市场：按医疗设备类型的估计和趋势分析

  • 细分仪表板：按治疗设备
  • 治疗设备的市场占有率及变化分析（2024 年及 2030 年）
  • 依治疗设备类型分類的市场规模预测及趋势分析（2018-2030年）
    • 可携带式氧气设备和人工呼吸器
    • 胰岛素帮浦
    • 助听器
    • 神经刺激设备
    • 智慧吸入器
    • 智慧型药物传输系统

第五章智慧治疗设备市场：按分销管道进行的估计和趋势分析

  • 细分仪表板：依分布
  • 各地区市场占有率及变化分析（2024年及2030年）
  • 按分销管道分類的市场规模预测和趋势分析（2018-2030 年）
  • 药局
    • 药局市场（2018-2030）
  • 线上管道
    • 线上通路市场（2018-2030）
  • 直接面向消费者（DTC）
    • 直接面向消费者 (DTC) 市场（2018-2030 年）
  • 其他（大卖场、专业零售商）
    • 其他（大卖场、专业零售商）市场（2018-2030）

第六章：智慧治疗设备市场：依最终用途的估计和趋势分析

  • 细分仪表板：依最终用途
  • 按最终用途分類的市场占有率及变化分析（2024 年及 2030 年）
  • 按最终用途分類的市场规模预测和趋势分析（2018-2030 年）
  • 医院
    • 医院市场（2018-2030）
  • 诊所
    • 诊所市场（2018-2030）
  • 居家医疗
    • 居家医疗市场（2018-2030）
  • 其他（运动、健身中心、辅助生活设施）
    • 其他（运动、健身中心、辅助生活）市场（2018-2030）

第七章智慧型治疗设备市场：按地区估计和趋势分析

  • 市场仪表板：按地区
  • 区域市场：关键要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 参与者概览
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Inogen, Inc.
    • Presspart Verwaltungs GmbH.
    • Cognita Labs
    • adherium
    • Medtronic
    • Hoffmann-La Roche AG
    • Insulet Corporation
    • Audicus
    • Eargo, Inc.
    • Nidek Medical Products, Inc.
    • Koninklijke Philips NV
    • Drive Devilbiss International
    • Tandem Diabetes Care, Inc.
    • Ypsomed
    • GN Hearing
    • Cochlear Ltd.
    • Sonova.
    • Boston Scientific Corporation
    • Abbott.
    • Nevro Corp.
Product Code: GVR-4-68040-606-7

Smart Therapeutic Devices Market Summary

The global smart therapeutic devices market size was estimated at USD 77.12 billion in 2024 and is projected to reach USD 159.42 billion by 2030, growing at a CAGR of 12.99% from 2025 to 2030. This growth is attributed to technological advancements, rising prevalence of chronic diseases, and the growing demand for personalized and home-based care.

This growth is attributed to technological advancements, rising prevalence of chronic diseases, and the growing demand for personalized and home-based care. Moreover, increasing adoption of portable and connected devices-such as insulin pumps, smart inhalers, and neurostimulation systems-has significantly enhanced disease management capabilities, particularly for conditions like diabetes, asthma, COPD, and neurological disorders. The integration of AI, data tracking, and wireless connectivity enables real-time monitoring, patient engagement, and clinical decision-making, thereby improving treatment outcomes and patient adherence.

With chronic disease management requiring continuous care, smart therapeutic devices bridge the gap between hospital visits and home-based healthcare, ultimately contributing to improved quality of life and reduced hospitalization rates. For instance, in July 2022, OMRON Healthcare launched a portable oxygen concentrator delivering 5L/min of >90% pure oxygen using PSA technology. Designed for home care, it features a compact, durable design with caster wheels for mobility.

Moreover, the trend toward personalized medicine continues to accelerate the adoption of smart technologies. For instance, in February 2024, Tandem Diabetes Care launched Tandem Mobi, the world's smallest durable automated insulin delivery system. This compact, wearable device offers full iOS mobile control, advanced Control-IQ technology, and compatibility with Dexcom CGMs, enabling personalized insulin therapy for users aged six and up.

According to the World Health Organization (WHO), as of 2024, noncommunicable diseases (NCDs) such as cardiovascular diseases, cancer, diabetes, and chronic respiratory conditions account for over 74% of global mortality annually. In response, the WHO is actively promoting greater investment in digital health solutions-including telemedicine and mobile health technologies-as a cost-effective strategy to manage and mitigate the impact of NCDs. Notably, an investment of merely USD 0.24 per patient per year in digital health interventions is projected to save over 2 million lives and prevent nearly 7 million acute events and hospitalizations over the next decade, thereby alleviating significant pressure on global healthcare systems.

These global imperatives are driving healthcare technology providers to expand and diversify their smart therapeutic device portfolios. A key example is GN's February 2025 launch of ReSound Vivia, touted as the world's smallest AI-powered hearing aid. Trained on 13.5 million real-world sentences, the device significantly enhances speech clarity in noisy environments while offering extended battery life of up to 30 hours for all-day use. GN also introduced ReSound Savi, a value-driven product line featuring Bluetooth LE Audio and Auracast broadcast capabilities-further democratizing access to advanced hearing solutions and aligning with global digital health priorities.

The COVID-19 pandemic significantly increased the demand for smart therapeutic devices like portable oxygen concentrators and ventilators became critical for managing respiratory complications. Smart inhalers, connected inhalers, and COPD management tools gained prominence due to the rise in respiratory illness awareness. On the other hand, insulin pumps, wearable injectors, and implantable drug delivery devices helped reduce hospital visits for chronic disease patients. The pandemic also pushed the adoption of neurostimulation and hearing devices through telehealth integration.

Global Smart Therapeutic Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global smart therapeutic devices market report based on devices, distribution, end use and regions.

  • Devices Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Portable Oxygen Concentrators & Ventilators
  • Insulin Pumps
  • Hearing Aids
  • Neurostimulation Devices
    • Spinal Cord Stimulation
    • Deep Brain Stimulation
    • Transcranial Magnetic Stimulation
  • Smart Inhalers
    • Asthma & COPD Management
    • Connected Inhalers with Data Tracking
  • Smart Drug Delivery Systems
    • Wearable Injectors
    • Implantable Drug Delivery Devices
  • Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmacies
  • Online Channel
  • Direct-to-Consumer (DTC)
  • Others (Hypermarkets, Specialty Retailers)
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Clinics
  • Home Care
  • Others (Sports, Fitness Centers, Assisted Living)
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Therapeutic Devices
    • 1.2.2. Device/Product
    • 1.2.3. Technology/Software
    • 1.2.4. Distribution
    • 1.2.5. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in personalized treatment plans
      • 3.2.1.2. Technological Advancements
      • 3.2.1.3. Rising Prevalence of Chronic Diseases
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Case Studies
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
  • 3.4. COVID 19 Impact Analysis

Chapter 4. Smart Therapeutics Devices Market: Therapeutic Devices Type Estimates & Trend Analysis

  • 4.1. Therapeutic Devices Segment Dashboard
  • 4.2. Therapeutic Devices Market Share Movement Analysis, 2024 & 2030
  • 4.3. Market Size & Forecasts and Trend Analysis, by Devices Type, 2018 to 2030 (USD Million)
    • 4.3.1. Portable Oxygen Concentrators & Ventilators
      • 4.3.1.1. Portable Oxygen Concentrators & Ventilators market, 2018 - 2030 (USD Million)
    • 4.3.2. Insulin Pumps
      • 4.3.2.1. Insulin Pumps market, 2018 - 2030 (USD Million)
    • 4.3.3. Hearing Aids
      • 4.3.3.1. Hearing Aids market, 2018 - 2030 (USD Million)
    • 4.3.4. Neurostimulation Devices
      • 4.3.4.1. Neurostimulation Devices market, 2018 - 2030 (USD Million)
      • 4.3.4.2. Spinal Cord Stimulation
        • 4.3.4.2.1. Spinal Cord Stimulation market, 2018 - 2030 (USD Million)
      • 4.3.4.3. Deep Brain Stimulation
        • 4.3.4.3.1. Deep Brain Stimulation market, 2018 - 2030 (USD Million)
      • 4.3.4.4. Transcranial Magnetic Stimulation
        • 4.3.4.4.1. Transcranial Magnetic Stimulation market, 2018 - 2030 (USD Million)
    • 4.3.5. Smart Inhalers
      • 4.3.5.1. Smart Inhalers market, 2018 - 2030 (USD Million)
      • 4.3.5.2. Asthma & COPD Management
        • 4.3.5.2.1. Asthma & COPD Management market, 2018 - 2030 (USD Million)
      • 4.3.5.3. Connected Inhalers with Data Tracking
        • 4.3.5.3.1. Connected Inhalers with Data Tracking market, 2018 - 2030 (USD Million)
    • 4.3.6. Smart Drug Delivery Systems
      • 4.3.6.1. Smart Drug Delivery Systems market, 2018 - 2030 (USD Million)
      • 4.3.6.2. Wearable Injectors
        • 4.3.6.2.1. Wearable Injectors market, 2018 - 2030 (USD Million)
      • 4.3.6.3. Drug Delivery Devices
        • 4.3.6.3.1. Drug Delivery Devices market, 2018 - 2030 (USD Million)

Chapter 5. Smart Therapeutics Devices Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Distribution Segment Dashboard
  • 5.2. Distribution Market Share Movement Analysis, 2024 & 2030
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 5.4. Pharmacies
    • 5.4.1. Pharmacies market, 2018 - 2030 (USD Million)
  • 5.5. Online Channel
    • 5.5.1. Online Channel market, 2018 - 2030 (USD Million)
  • 5.6. Direct-to-Consumer (DTC)
    • 5.6.1. Direct-to-Consumer (DTC) market, 2018 - 2030 (USD Million)
  • 5.7. Others (Hypermarkets, Specialty Retailers)
    • 5.7.1. Others (Hypermarkets, Specialty Retailers) market, 2018 - 2030 (USD Million)

Chapter 6. Smart Therapeutics Devices Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. End Use Market Share Movement Analysis, 2024 & 2030
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market, 2018 - 2030 (USD Million)
  • 6.5. Clinics
    • 6.5.1. Clinics market, 2018 - 2030 (USD Million)
  • 6.6. Home Care
    • 6.6.1. Home Care market, 2018 - 2030 (USD Million)
  • 6.7. Others (Sports, Fitness Centers, Assisted Living)
    • 6.7.1. Others (Sports, Fitness Centers, Assisted Living) market, 2018 - 2030 (USD Million)

Chapter 7. Smart Therapeutics Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market: Key Takeaways
  • 7.3. North America
    • 7.3.1. North America smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamic
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive insights
      • 7.3.2.4. U.S. smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamic
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive insights
      • 7.3.3.4. Canada smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamic
      • 7.3.4.2. Regulatory framework
      • 7.3.4.3. Competitive insights
      • 7.3.4.4. Mexico smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamic
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive insights
      • 7.4.2.4. Germany smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key country dynamic
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive insights
      • 7.4.3.4. UK smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamic
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive insights
      • 7.4.4.4. France smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamic
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive insights
      • 7.4.5.4. Italy smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamic
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive insights
      • 7.4.6.4. Spain smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key country dynamic
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive insights
      • 7.4.7.4. Denmark smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamic
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive insights
      • 7.4.8.4. Sweden smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamic
      • 7.4.9.2. Regulatory framework
      • 7.4.9.3. Competitive insights
      • 7.4.9.4. Norway smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamic
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive insights
      • 7.5.2.4. Japan smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamic
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive insights
      • 7.5.3.4. China smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamic
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive insights
      • 7.5.4.4. India smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamic
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive insights
      • 7.5.5.4. South Korea smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamic
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive insights
      • 7.5.6.4. Australia smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamic
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive insights
      • 7.5.7.4. Thailand smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America smart therapeutics devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamic
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive insights
      • 7.6.2.4. Brazil smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamic
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive insights
      • 7.6.3.4. Argentina smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamic
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive insights
      • 7.7.2.4. South Africa smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamic
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive insights
      • 7.7.3.4. Saudi smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamic
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive insights
      • 7.7.4.4. UAE smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamic
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive insights
      • 7.7.5.4. Kuwait smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Inogen, Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. Presspart Verwaltungs GmbH.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Cognita Labs
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. adherium
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Medtronic
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. Hoffmann-La Roche AG
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. Insulet Corporation
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Audicus
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Eargo, Inc.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Products & Services benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Nidek Medical Products, Inc.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Koninklijke Philips N.V.
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. Drive Devilbiss International
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Tandem Diabetes Care, Inc.
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. Ypsomed
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. GN Hearing
      • 8.5.15.1. Overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Cochlear Ltd.
      • 8.5.16.1. Overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product benchmarking
      • 8.5.16.4. Strategic initiatives
    • 8.5.17. Sonova.
      • 8.5.17.1. Overview
      • 8.5.17.2. Financial performance
      • 8.5.17.3. Product benchmarking
      • 8.5.17.4. Strategic initiatives
    • 8.5.18. Boston Scientific Corporation
      • 8.5.18.1. Overview
      • 8.5.18.2. Financial performance
      • 8.5.18.3. Product benchmarking
      • 8.5.18.4. Strategic initiatives
    • 8.5.19. Abbott.
      • 8.5.19.1. Overview
      • 8.5.19.2. Financial performance
      • 8.5.19.3. Product benchmarking
      • 8.5.19.4. Strategic initiatives
    • 8.5.20. Nevro Corp.
      • 8.5.20.1. Overview
      • 8.5.20.2. Financial performance
      • 8.5.20.3. Product benchmarking
      • 8.5.20.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America smart therapeutic devices market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 5 North America smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 8 U.S. smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 U.S. smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 11 Canada smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 12 Canada smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 14 Mexico smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Mexico smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Europe smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 17 Europe smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 Europe smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 20 UK smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 21 UK smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Germany smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 23 Germany smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 Germany smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 26 France smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 27 France smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 29 Italy smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Italy smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 32 Spain smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 33 Spain smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Norway smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 35 Norway smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 36 Norway smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 38 Sweden smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 Sweden smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Denmark smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 41 Denmark smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42 Denmark smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific smart therapeutic devices market, by country, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 48 Japan smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 Japan smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 50 China smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 51 China smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 China smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 54 India smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 India smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 57 Australia smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58 Australia smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
  • Table 60 South Korea smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 South Korea smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 63 Thailand smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 64 Thailand smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America smart therapeutic devices market, by country, 2018 - 2030 (USD Million)
  • Table 66 Latin America smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 67 Latin America smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 68 Latin America smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Brazil smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 70 Brazil smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 71 Brazil smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 73 Argentina smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 74 Argentina smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa smart therapeutic devices market, by country, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 77 Middle East & Africa smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 78 Middle East & Africa smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 79 South Africa smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 80 South Africa smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 81 South Africa smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE smart therapeutic devices market, devices types , 2018 - 2030 (USD Million)
  • Table 86 UAE smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 87 UAE smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
  • Table 89 Kuwait smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 90 Kuwait smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Smart therapeutics devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market formulation & validation
  • Fig. 6 Market research approaches
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD modelling for market share assessment
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Market snapshot
  • Fig. 11 Market segmentation (USD Million
  • Fig. 12 Competitive landscape
  • Fig. 13 Parent market outlook (In USD Billion)
  • Fig. 14 Related/ancillary market outlook (In USD Billion)
  • Fig. 15 Smart therapeutics devices market dynamics
  • Fig. 16 Smart therapeutics devices market: Porter's five forces analysis
  • Fig. 17 Smart therapeutics devices market: PESTLE analysis
  • Fig. 18 Smart therapeutics devices market: Devices Type segment dashboard
  • Fig. 19 Smart therapeutics devices market: Devices Type market share analysis, 2024 & 2030
  • Fig. 20 Portable Oxygen Concentrators & Ventilators market, 2018 - 2030 (USD Million)
  • Fig. 21 Insulin Pumps market, 2018 - 2030 (USD Million)
  • Fig. 22 Hearing Aids market, 2018 - 2030 (USD Million)
  • Fig. 23 Neurostimulation Devices market, 2018 - 2030 (USD Million)
  • Fig. 24 Spinal Cord Stimulation market, 2018 - 2030 (USD Million)
  • Fig. 25 Deep Brain Stimulation market, 2018 - 2030 (USD Million)
  • Fig. 26 Transcranial Magnetic Stimulation market, 2018 - 2030 (USD Million)
  • Fig. 27 Smart Inhalers market, 2018 - 2030 (USD Million)
  • Fig. 28 Asthma & COPD Management market, 2018 - 2030 (USD Million)
  • Fig. 29 Connected Inhalers with Data Tracking market, 2018 - 2030 (USD Million)
  • Fig. 30 Smart Drug Delivery Systems market, 2018 - 2030 (USD Million)
  • Fig. 31 Wearable Injectors market, 2018 - 2030 (USD Million)
  • Fig. 32 Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Smart therapeutic devices market: Distribution market share analysis, 2024 & 2030
  • Fig. 34 Pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 35 Online Channel market, 2018 - 2030 (USD Million
  • Fig. 36 Direct-to-Consumer (DTC) market, 2018 - 2030 (USD Million
  • Fig. 37 Others (Hypermarkets, Specialty Retailers) market, 2018 - 2030 (USD Million
  • Fig. 38 Smart therapeutic devices market: End use market share analysis, 2024 & 2030
  • Fig. 39 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 40 Clinics market, 2018 - 2030 (USD Million)
  • Fig. 41 Home Care market, 2018 - 2030 (USD Million)
  • Fig. 42 Others (Sports, Fitness Centers, Assisted Living) market, 2018 - 2030 (USD Million)
  • Fig. 43 Smart therapeutic devices market revenue, by region
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 North America smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 US smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Canada smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Mexico smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 52 Europe smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 UK smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Germany smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 France smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Italy smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Spain smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Sweden smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Denmark smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Japan smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 China smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 India smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Australia smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Korea smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Thailand smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Brazil smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Argentina smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 87 MEA smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 South Africa smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Saudi Arabia smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 UAE smart therapeutic devices market, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Kuwait healthcare information system market, 2018 - 2030 (USD Million)
  • Fig. 96 Company categorization
  • Fig. 97 Company market position analysis
  • Fig. 98 Strategic framework